A randomised trial of intensive bisphosphonate therapy versus symptomatic treatment for Paget's disease of bone

被引：0
|
作者：
Langston, A. L.
Fraser, W. D.
Selby, P. L.
Campbe, M. K.
MacLennan, G.
Ralston, S. H.
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Univ Liverpool, Liverpool, Merseyside, England
[3] Univ Manchester, Manchester, Lancs, England
[4] Univ Aberdeen, Aberdeen, Scotland
来源：
BONE | 2007年 / 40卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S161 / S161
页数：1
相关论文
共 50 条
  • [31] Bisphosphonate use in Paget's disease
    Hosking, D
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S101 - S101
  • [32] FAVORABLE OUTCOME OF PAGET'S DISEASE OF THE BONE AFTER 4 YEARS OF DISCONTINUATON OF ORAL BISPHOSPHONATE THERAPY
    Rosca, R. I.
    Dumitrascu, A. S.
    Vladoiu, S.
    Goldstein, A.
    Arnautu, A. M.
    Tilici, D. M.
    Nacea, C. A.
    Miulescu, R. Danciulescu
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S391 - S392
  • [33] Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone
    Siris, E
    Weinstein, RS
    Altman, R
    Conte, JM
    Favus, M
    Lombardi, A
    Lyles, K
    McIlwain, H
    Murphy, WA
    Reda, C
    Rude, R
    Seton, M
    Tiegs, R
    Thompson, D
    Tucci, JR
    Yates, AJ
    Zimering, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03): : 961 - 967
  • [34] Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone
    Martini, G.
    Gennari, L.
    Merlotti, D.
    Salvadori, S.
    Franci, M. B.
    Campagna, S.
    Avanzati, A.
    De Paola, V.
    Valleggi, F.
    Nuti, R.
    BONE, 2007, 40 (02) : 457 - 463
  • [35] Computer-assisted quantitative evaluation of bisphosphonate treatment for Paget's disease of bone using the bone scan index
    Nagano, Satoshi
    Nakamura, Shunsuke
    Shimada, Hirofumi
    Yokouchi, Masahiro
    Setoguchi, Takao
    Ishidou, Yasuhiro
    Sasaki, Hiromi
    Komiya, Setsuro
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (06) : 3830 - 3836
  • [36] Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone.: Proposed intervals for monitoring treatment
    Alvarez, L
    Peris, P
    Guañabens, N
    Vidal, S
    Quintó, L
    Monegal, A
    Pons, F
    Ballesta, AM
    Muñoz-Gómez, J
    RHEUMATOLOGY, 2004, 43 (07) : 869 - 874
  • [37] Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
    Merlotti, D.
    Gennari, L.
    Martini, G.
    Valleggi, F.
    De Paola, V.
    Salvadori, S.
    Avanzati, A.
    Nuti, R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S38 - S38
  • [38] Alendronate in the treatment of Paget's disease of bone
    Khan, SA
    Vasikaran, S
    McCloskey, EV
    Beneton, MNC
    Rogers, S
    Coulton, L
    Orgee, J
    Coombes, G
    Kanis, JA
    BONE, 1997, 20 (03) : 263 - 271
  • [39] Diagnosis and treatment of Paget's disease of bone
    Schneider, D
    Hofmann, MT
    Peterson, JA
    AMERICAN FAMILY PHYSICIAN, 2002, 65 (10) : 2069 - 2072
  • [40] Treatment of patients with Paget's disease of bone
    Roux, C
    Dougados, M
    DRUGS, 1999, 58 (05) : 823 - 830
12345